You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

icotinib

Showing 26 - 50 of 60
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EGFR Positive NSCLC, Adenocarcinoma Trial in Beijing (Icotinib, Placebo)

Unknown status
  • EGFR Positive Non-small Cell Lung Cancer
  • Adenocarcinoma
  • Icotinib
  • Placebo
  • Beijing, Beijing, China
  • +10 more
Jul 12, 2018

Non-Small-Cell Lung Trial in Suzhou (Anlotinib Hydrochloride, Gefitinib, Icotinib)

Unknown status
  • Non-Small-Cell Lung
  • Anlotinib Hydrochloride
  • +2 more
  • Suzhou, Jangsu, China
    The First Affiliated hospital of soochow university
Jan 28, 2019

Nasopharyngeal Carcinoma Trial in Taizhou (drug, radiation, other, genetic)

Completed
  • Nasopharyngeal Carcinoma
  • Icotinib
  • +4 more
  • Taizhou, Zhejiang, China
    Taizhou Hospital, Wenzhou Medical College
Apr 16, 2018

Plasma EGFR Mutation-positive Lung Cancer Trial in Beijing (Icotinib)

Unknown status
  • Plasma EGFR Mutation-positive Lung Cancer
  • Icotinib
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital
Nov 15, 2017

NSCLC Trial in Beijing (icotinib)

Unknown status
  • NSCLC
  • icotinib
  • Beijing, China
    Beijing Chest Hospital, Capital Medical University
Jul 27, 2017

Lung Cancer Stage IV Trial (Icotinib, SBRT)

Unknown status
  • Lung Cancer Stage IV
  • Icotinib
  • SBRT
  • (no location specified)
May 13, 2017

NSCLC Trial in Hefei (Icotinib)

Unknown status
  • NSCLC
  • Icotinib
  • Hefei, Anhui, China
    Dept. of Oncology,The First Affiliated Hospital of Anhui Medical
May 3, 2017

Brain Metastasis, Non Small Cell Lung Cancer Trial in Guangzhou (whole brain radiation(WBI), Icotinib)

Completed
  • Brain Metastasis
  • Non Small Cell Lung Cancer
  • whole brain radiation(WBI)
  • Icotinib
  • Guangzhou, Guangdong, China
  • +1 more
Feb 28, 2017

NSCLC Trial in Beijing (Icotinib)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • Icotinib
  • Beijing, China
    Chinese Academy of Medical Sciences
Nov 16, 2016

NSCLC Trial in Beijing (Icotinib)

Unknown status
  • Non-small Cell Lung Cancer
  • Icotinib
  • Beijing, China
    Department of Medical Oncology, Cancer Hospital, Chinese Academy
Nov 10, 2016

NSCLC Trial (icotinib, Chemotherapy, Radiotherapy)

Unknown status
  • Non-small Cell Lung Cancer
  • icotinib
  • +2 more
  • (no location specified)
Aug 29, 2016

NSCLC(NSCLC) Trial in Beijing (Icotinib)

Recruiting
  • Non-small Cell Lung Cancer(NSCLC)
  • Icotinib
  • Beijing, Beijing, China
    Beijing Haidian Hospital
Jun 29, 2016

Esophageal Cancer Trial in Hangzhou (Icotinib, Thoracic radiotherapy)

Unknown status
  • Esophageal Cancer
  • Icotinib
  • Thoracic radiotherapy
  • Hangzhou, Zhejiang, China
    Hangzhou Cancer Hospital
Mar 18, 2016

Non-Small-Cell Lung Cancer Trial in Jinan (Erlotinib, Gefitinib, Icotinib)

Unknown status
  • Non-Small-Cell Lung Cancer
  • Jinan, Shandong, China
    Yu Li
Mar 28, 2016

NSCLC Trial in Shanghai (Icotinib)

Unknown status
  • Non-Small Cell Lung Cancer
  • Icotinib
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital Affliated to Shanghai Jiaotong Univercit
Sep 5, 2015

Pancreatic Cancer Trial in Hangzhou (icotinib, Gemcitabine)

Unknown status
  • Pancreatic Cancer
  • Hangzhou, China
    Second Affiliated Hospital of Zhejiang Univercity School of Medc
Jul 14, 2015

NSCLC Trial in Guangzhou (icotinib)

Unknown status
  • Non-small Cell Lung Cancer
  • icotinib
  • Guangzhou, Guangdong, China
    Sun Yat-sen Cancer Center
Jul 14, 2015

Non-small-cell Lung Cancer Trial in Hangzhou (Icotinib, Chemotherapy)

Unknown status
  • Non-small-cell Lung Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang cancer hospital
Jul 14, 2015

NSCLC Trial in China (icotinib)

Completed
  • Non-small Cell Lung Cancer
  • icotinib
  • Beijing, Beijing, China
  • +9 more
Jun 28, 2015

NSCLC Trial in Changsha (Icotinib)

Suspended
  • Non-small Cell Lung Cancer
  • Icotinib
  • Changsha, Hunan, China
    Xiangya Hospital, Central-South Univercity
May 21, 2015

Pancreatic Cancer Trial in Harbin, Changchun, Shenyang (icotinib, Gemcitabine)

Unknown status
  • Pancreatic Cancer
  • Harbin, Heilongjiang, China
  • +2 more
May 21, 2015

NSCLC Trial (Icotinib)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • Icotinib
  • (no location specified)
Apr 26, 2015

EGFR Positive NSCLC, Adenocarcinoma Trial in China (Sequential Icotinib Plus Chemotherapy, Icotinib)

Unknown status
  • EGFR Positive Non-small Cell Lung Cancer
  • Adenocarcinoma
  • Sequential Icotinib Plus Chemotherapy
  • Icotinib
  • Lanzhou, Gansu, China
  • +30 more
Apr 27, 2015

NSCLC Trial in Nanning (Icotinib, Pemetrexed, Carboplatin)

Unknown status
  • Non-small Cell Lung Cancer
  • Icotinib
  • +3 more
  • Nanning, Guangxi, China
    The people's Hospital of the Guangxi Zhuang Autonomous Region
Mar 30, 2015

Squamous Cell Carcinoma of Lung Trial in Hangzhou (Icotinib)

Unknown status
  • Squamous Cell Carcinoma of Lung
  • Icotinib
  • Hangzhou, Zhejiang, China
    79 Qingchun Road
Mar 4, 2015